Literature DB >> 3620302

Histochemical studies of human breast cancer using a monoclonal antibody against an oestrogen receptor-related antigen.

R A Hawkins, K Sangster, A Krajewski.   

Abstract

The presence or absence of an oestrogen receptor-related antigen in breast tumours has been examined histochemically using a monoclonal antibody ('Ds' - Coffer & King, 1981). In frozen sections, fixed either by the method of Tamura et al. (1980) or in methanol, staining was apparent in 14/24 (58%) and 22/26 (85%) of the breast cancers respectively. In paraffin sections fixed in ethanol, staining was present in 25/33 breast cancers (76%). In either type of section, staining was predominantly in the cytoplasm of the epithelial cells. When staining was scored by independent observers (2 or 3) and related to the tumour oestrogen receptor activity, determined by a standard biochemical technique, antigen was present in both receptor-positive and receptor-negative tumours. No significant association was found between the presence of antigen and receptors in the frozen sections, but for the series of paraffin sections, there was a weak association (r = +0.48) between the presence of the two proteins. Histochemical processing of paraffin sections from 9 tumours under conditions of higher sensitivity increased the staining significantly in 2/9 tumours, but did not alter the relationship between staining and receptor status. Six tissues were stained after exposure to 'receptor-translocating' conditions (25 degrees C/2 nM oestradiol/both for 1 h): this did not consistently change the subcellular staining pattern, though all tissues tended to stain more after exposure to 25 degrees C. Staining was not blocked by absorption of the D5 antiserum with a variety of pure proteins or human serum but at higher concentrations (approx. 2-15 mg protein ml-1), extracts from human uterus, an oestrogen-receptor-positive breast cancer and an oestrogen-receptor-negative breast cancer all effectively abolished staining in sections from another breast cancer. These results are consistent with other reports suggesting that the D5 antibody detects an antigen which is not the oestrogen receptor, but which may be associated with the receptor in its tissue distribution.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3620302      PMCID: PMC2002028          DOI: 10.1038/bjc.1987.124

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  18 in total

Review 1.  Estrogen-receptor interaction.

Authors:  E V Jensen; E R DeSombre
Journal:  Science       Date:  1973-10-12       Impact factor: 47.728

2.  Cytochemical study of estrogen receptor in human mammary cancer.

Authors:  S H Lee
Journal:  Am J Clin Pathol       Date:  1978-08       Impact factor: 2.493

3.  An update on the immunohistochemical localization of estrogen receptors in mammary carcinomas utilizing polyclonal anti-receptor antibodies.

Authors:  H Tamura; S Raam; A Smeedy; C A Pappas
Journal:  Eur J Cancer Clin Oncol       Date:  1984-10

4.  Monoclonal antibodies to estrophilin: probes for the study of estrogen receptors.

Authors:  G L Greene; F W Fitch; E V Jensen
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

Review 5.  Oestrogen receptors and breast cancer: current status.

Authors:  R A Hawkins; M M Roberts; A P Forrest
Journal:  Br J Surg       Date:  1980-03       Impact factor: 6.939

6.  Antibodies to estradiol receptor from human myometrium.

Authors:  A I Coffer; R J King
Journal:  J Steroid Biochem       Date:  1981-12       Impact factor: 4.292

7.  An improved histochemical method for detection of estrogen receptors in mammary cancer. Comparison with biochemical assay.

Authors:  L P Pertschuk; E Gaetjens; A C Carter; D J Brigati; D S Kim; T E Fealey
Journal:  Am J Clin Pathol       Date:  1979-05       Impact factor: 2.493

8.  Histological detection of oestrogen receptor in human breast carcinomas.

Authors:  R A Walker; D H Cove; A Howell
Journal:  Lancet       Date:  1980-01-26       Impact factor: 79.321

9.  Oestrogen receptor concentration in primary breast cancer and axillary node metastases.

Authors:  R A Hawkins; R Black; R J Steele; J M Dixon; A P Forrest
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

10.  Histochemical detection of oestrogen receptors in breast carcinoma: a successful technique.

Authors:  R A Hawkins; K Sangster; A Krajewski
Journal:  Br J Cancer       Date:  1986-03       Impact factor: 7.640

View more
  1 in total

1.  Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer.

Authors:  C Wright; S Nicholson; B Angus; J R Sainsbury; J Farndon; J Cairns; A L Harris; C H Horne
Journal:  Br J Cancer       Date:  1992-01       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.